Your Expert Partner in Gene TherapyIndustry-leading expertise in adeno-associated viral vector (AAV) development and manufacturing Learn More Introducing OneBioSM SuiteAccelerating timelines through integrated biologics development, manufacturing & supply Learn More Your one comprehensive BIOLOGICS partnerHelping simplify your process and deliver better therapies to your patients faster Play Video Your Expert Partner in Gene TherapyIndustry-leading expertise in adeno-associated viral vector (AAV) development and manufacturing Learn More Introducing OneBioSM SuiteReducing timelines, risk & complexity through integrated biologics development, manufacturing & supply Learn More Your one comprehensive BIOLOGICS partnerHelping simplify your process and deliver better therapies to your patients faster Play Video How can we work together BiologicsDevelopment Drug SubstanceBiomanufacturing Drug ProductFill / Finish Clinical SupplyServices Latest News Catalent Biologics Announces Agreement to Provide Additional Production of Approved Gene Therapy Treatment for Spinal Muscular Atrophy WEBINAR: CASE STUDIES IN EXPEDITING BIOLOGIC DEVELOPMENT Biologic drug development is complex, which can add costs and delays. This webinar covers challenges and tools for risk mitigation during biologic development and manufacturing. Gene Therapy With 40+ active gene therapy programs and leading expertise in Adeno Associate Viral (AAV) Vectors, Paragon Gene Therapy will provide you with full life cycle support of your life-saving therapeutic. Join Our Team Catalent is growing in Biologics and is making significant investments in people in this area. Explore global career opportunities with our Biologics team. Biologics Network Our network of biologics sites provides an integrated approach to get medicines to your patients faster anywhere in the world. See all of our locations NEWS Enhanced Cell Line Productivity Technology to be Introduced by Catalent Biologics at PEGS Europe Catalent to Discuss the Future of Cell and Gene Therapy Manufacturing at World Orphan Drug Congress Europe Catalent Biologics Launches GPEx® Boost Cell Line Expression Technology to Improve Titers and Cell-Specific Productivity Catalent Announces the Appointment of David Schaffer to Biologics Advisory Board EVENTS PEGS Europe 2019 DDL 2019 Webinar | You’ve Got That Coveted Accelerated Regulatory Pathway. Now What? JPMorgan Healthcare Conference EXPERT CONTENT Advances in Analytical Technology for Biopharmaceuticals Prefilled Syringes & Parental Manufacturing Accelerating Method Transfer: Effective Automation Of Biological Assays
